Satellite symposia - 12th Congress of ECCO

Satellite symposia are organised by pharmaceutical companies. These symposia are open to all congress participants. Responsibility for the programme content remains by the sponsor.

ECCO has scheduled parallel satellite symposia on Thursday, February 16, 2017 at 11:30-12:30 and at 17:45-18:45, on Friday, February 17, 2017 at 07:15-08:15 and at 18:30-19:30, and on Saturday, February 18, 2017 at 07:15-08:15. Furthermore, educational lunchtime satellite symposia are scheduled for Friday,  February 17, 2017 at 12:40-13:20.

Satellite symposia are held in the main Plenary hall (Ground Level) and respectively in the Parallel hall (Room 116+117) on Level 1.

Lunchtime satellite symposia are held in the main Plenary hall (Ground Level), respectively in Parallel hall (Room 116+117) on Level 1, Room 111 and the Room 113 (ground floor) 

The programme of satellite symposia are not affiliated with ECCO. 

 

Satellite symposia

  • 2nd ECCO Endoscopy Workshop satellite symposium: Medtronic
    Room 122+123, Level 1, CCIB

    Medtronic logo tagline cmyk jpeg

    11:45-12:45 Impact of the capsule endoscopy (CE) on Crohn's management: A Pan-intestinal capsule for a pan-intestinal disease
    Invitation to Satellite Symposium

    Chairs: Vito Annese, Florence, Italy
    11:45-12:05 The siginificance of small bowel involvement in Crohn's Disease
    Joerg Albert, Frankfurt, Germany
    12:05-12:25 Endoscopic assessment of bowel mucosal activity: Role of capsule endoscopy to monitor Crohn's Disease patient
    Bruno Rosa, Guimaraes, Portugal
    12:25-12:45 A pan-intestinal tool for a pan-intestinal disease
    Rami Eliakim, Tel Aviv, Israel

    15th IBD Intensive Advanced Course satellite symposium: Vifor Pharma
    Room 111, Level 1, CCIB

    Vifor Pharma

    16:00-17:00 Case-based learning: Managing iron deficiency in different clinical IBD-patient situations
    Invitation to Satellite Symposium
    Chairs: Stephan Vavricka, Zurich, Switzerland
    16:00-16:05 Welcome and introduction
    Stephan Vavricka, Zurich, Switzerland
    16:05-16:20 Iron deficiency pathways
    Jan Wehkamp, Tubingen, Germany
    16:20-16:50 Special clinical situations (patient cases)
      16:20-16:35 Managing iron deficiency in a newly diagnosed acute IBD patient
    Antonio López San Román, Madrid, Spain
      16:35-16:50 Managing iron deficiency in a chronic IBD patient
    Philip Esters, Frankfurt, Germany
    16:50-17:00 Summary and conclusions
    Stephan Vavricka, Zurich, Switzerland
  • Satellite Symposium 1a: Pfizer
    Plenary Hall, Ground level, CCIB Barcelona

    Pfizer





    11:30-12:30 Patient and clinical perspectives: Understanding current pitfalls and recognizing new therapeutic possibilities in Ulcerative Colitis
    Invitation to Satellite Symposium

    Chair: Stephen Hanauer, Chicago, United States
    11:30-11:35 Welcome and introduction

    11:35-11:50 The patient journey of living with Ulcerative Colitis
    Alessandro Armuzzi, Rome, Italy
    11:50-12:05 Unmet needs, challenges and limitations of current management of Ulcerative Colitis
    Peter Irving, London, United Kingdom
    12:05-12:20 Beyond bilogics: Emerging therapies in Ulcerative Colitis
    Stephen Hanauer, Chicago, United States
    12:20-12:30 Audience Q&A

    Satellite symposium 1b:  Pfizer
    Parallel hall, Room 116+117, Level 1, CCIB Barcelona

    Pfizer

    11:30-12:30 Talking points in IBD:
    - Evidence based switching to biosimilar
    - A pathway towards personalised medicine
    Invitation to Satellite Symposium

    Chair: James Lindsay, London, United Kingdom
    Expert panelists: Chris Probert, Liverpool, United Kingdom
                                    Stefan Schreiber, Kiel, Germany
    Talking point 1
     
    11:30-12:00 Biosimilars in IBD: To switch or not to switch?
    Peter Lakatos, Budapest, Hungary
    Expert Panel Debate
    Talking point 2
     
    12:00-12:30 Pesonalised medicine in IBD: Rhetoric or reality?
    Walter Reinisch, Vienna, Austria
    Expert Panel Debate

    11th N-ECCO Network Meeting satellite symposium: Takeda
    Room 112, Level 1, CCIB Barcelona

    Takeda

    12:45-13:45 IBD nursing in the real world
    Invitation to Satellite Symposium

    Chair: Usha Chauhan, Hamilton, Canada
    12:45-12:50 Introduction to IBD nursing today
    Usha Chauhan, Hamilton, Canada
    12:50-13:00 Plenary session: Understanding and communicating complex immunology concepts
    Alexander Moschen, Innsbruck, Austria
    13:00-13:15 Plenary session: Understanding IBD patient psychology
    Yoram Inspector, Harrow, United Kingdom
    13:15-13:40 Interactive panel discussion: IBD nursing in the real worl
    Michaela Schara, Dreistetten, Austria
    Yoram Inspector, Harrow, United Kingdom
    Alexander Moschen, Innsbruck, Austria
    Usha Chauhan, Hamilton, Canada
    13:40-13:45 Q&A session and concluding remarks
    Usha Chauhan, Hamilton, Canada

    Satellite symposium 2a: AbbVie
    Plenary Hall, Ground Level, CCIB Barcelona

     AbbVieLogo updated symposia 16

    17:45-18:45 Tackling the burden of IBD
    Invitation to Satellite Symposium

    Chair: Subrata Ghosh, Birmingham, United Kingdom
    17:45-17:50 Welcome and introductions
    Subrata Ghosh, Birmingham, United Kingdom
    17:50-18:05 Beyond the symptoms: Societal impact of IBD
    David T. Rubin, Chicago, United States
    08:05-18:20 Patient in focus: The personal burden of IBD
    Subrata Ghosh, Birmingham, United Kingdom
    18:20-18:35 Reducing the burden: Successful management of IBD
    Edouard Louis, Liege, Belgium
    18:35-18:45 Summary and Q&A
    Subrata Ghosh, Birmingham, United Kingdom
    Panel

    Satellite symposium 2b: Shire
    Parallel hall, Room 116+117,Level 1, CCIB Barcelona              

    Shire



       
    17:45-18:45 Optimising the IBD journey from early intervention to management of intestinal failure
    Invitation to Satellite Symposium

    Chair: Remo Panaccione, Calgary, Canada
    17:45-18:17 Session 1
      17:45-17:48 Welcome and introductions
    Remo Panaccione, Calgary, Canada
      18:48-18:00 Are we getting the most from our IBD medicines?
    Peter Irving, London, United Kingdom
      18:00-18:12 Defining evidence-based therapeutic goals for treat-to-target in IBD
    Remo Panaccione, Calgary, Canada
      18:12-18:17 Q&A
    Remo Panaccione, Calgary, Canada
    18:25-18:45 Session 2
      18:25-18:28 Welcome and introductions
    Remo Panaccione, Calgary, Canada
      18:28-18:40 Short bowel syndrome and intestinal failure in IBD: Current challenges and treatment options
    Jean-Frédéric Colombel, New York, United States
      18:40-18:45 Q&A
    Remo Panaccione, Calgary, Canada
  • Satellite symposium 3a: Takeda
    Plenary Hall, Ground Level, CCIB Barcelona  

    Takeda 
       

    07:15-08:15 Changing the game in Ulcerative Colitis: Impact of gut-selective therapy
    Invitation to Satellite Symposium

    Chair: Jean-Frédéric Colombel, New York, United States
     07:15-07:20 Welcome and introduction
    Jean-Frédéric Colombel, New York, United States
     07:20-07:30 Resetting expectations for therapy in Ulcerative Colitis
    Jean-Frédéric Colombel, New York, United States
     07:30-07:45 Remission in Ulcerative Colitis: Has it been achieved and for how long?
    Brian Feagan, London, Canada
     07:45-08:05 Meeting expectations for therapy: Do Gut-Selective Biologics deliver?
    Stefan Schreiber, Kiel, Germany
    08:05-08:15 Panel Discussion/Q&A
    Jean-Frédéric Colombel, New York, United States
     
     

    Satellite symposium 3b: Tillotts
    Parallel Hall, Room 116+117, Level 1, CCIB Barcelona

    1 2 logo tillotts

    07:15-08:15 Mild-to-Moderate IBD management: Challenges beyond inflammation
    Invitation to Satellite Symposium

    Chair: Gerhard Rogler, Zurich, Switzerland
    07:15-07:25 Welcome
    Gerhard Rogler, Zurich, Switzerland
    07:25-07:45 Treatment of Mild-to-Moderate IBD in the elderly
    Ian Arnott, Edinburgh, Scotland
    07:45-08:05 The relevance of PROs and biomarkers in clinical practice
    Jonas Halfvarson, Orebro, Sweden
    08:05-08:10 Panel discussion/Q&A
    08:10-08:15 Closing remarks
    Gerhard Rogler, Zurich, Switzerland

    Satellite symposium LS1: Takeda
    Plenary Hall, Ground Level, CCIB Barcelona

    Takeda

    12:40-13:20 Targeting disease progression in Crohn's Disease: Fighting an unrelenting enemy
    Invitation to Satellite Symposium

    Chair: Iris Dotan, Tel Aviv, Israel
    12:40-12:45 Welcome & introduction
    Iris Dotan, Tel Aviv, Israel
    12:45-13:00 Slowing progression of Crohn's Disease: Decisive treatment for early and long-term remission
    Remo Panaccione, Calgary, Canada
    13:00-13:15 Early use of Gut-Selective therapy in Crohn's Disease for Long-term remission
    Iris Dotan, Tel Aviv, Israel
    13:15-13:20 Q&A
    Iris Dotan, Tel Aviv, Israel

    Satellite symposium LS2: MSD
    Parallel Hall, Room 116+117, Level 1, CCIB Barcelona

    1 2 logo msd

    12:40-13:20 It's time to get Ulcerative Colitis under Continuous Control
    Invitation to Satellite Symposium

    Chair: Gert Van Assche, Leuven, Belgium
    12:40-12:50 Introduction: Why do we need to achieve continuous control of disease activity in Ulcerative Colitis
    Gert Van Assche, Leuven, Belgium
    12:50-13:20 Interactive discussion: Benefit of Continuous Clinical Response (CCR) for patients and HCPs. PRO2 and other outcome measures for Ulcerative Colitis patients
    Gert Van Assche, Leuven, Belgium
    James Lindsay, London, United Kingdom

    Satellite symposium LS3: Nikkiso
    Room 111, Level 1, CCIB Barcelona

    NIKKISO

    12:40-13:20 New treatment option in second-line Ulcerative Colitis patients
    Invitation to Satellite Symposium
    Chairs: Wolfgang Kruis, Cologne, Germany
                Axel Dignass, Frankfurt, Germany
    12:40-12:45 Welcome and opening
    Wolfgang Kruis, Cologne, Germany
    Axel Dignass, Frankfurt, Germany
    12:45-13:10 Novel Leukocyte/Thrombocyte Apheresis for induction of remission in Ulcerative Colitis: A controlled, randomized pilot study
    Wolfgang Kruis, Cologne, Germany
    13:10-13:15 An open label, multicenter, post-marketing clinical investigation on the efficacy and safety of twice-a-week leukapheresis in Mild-to-Moderate active Ulcerative Colitis: An interim analysis.
    Alessandro Armuzzi, Rome, Italy
    Gionata Fiorino, Milan, Italy
    13:15-13:20 Questions & Answers/Discussion/Closing remarks
    Wolfgang Kruis, Cologne, Germany
    Axel Dignass, Frankfurt, Germany

    Satellite symposium LS4: Celltrion
    Room 113, Level 1, CCIB Barcelona

    Celltrionhealthcare 500px

    12:40-13:20 Witness the evolving landscape of IBD treatment driven by evidence
    Invitation to Satellite Symposium

    Chair: Stefan Schreiber, Kiel, Germany
    12:40-12:45 Welcome & opening
    Stefan Schreiber, Kiel, Germany
    12:45-12:55 Perceptual evolution on Biosimilar mAb
    Walter Reinisch, Vienna, Austria
    12:55-13:05 Another step towards evidence based extrapolation_3.4 CD
    Young Ho Kim, Seoul, Republic of Korea
    13:05-13:15 Another step towards evidence based switching_NOR-SWITCH:
    Jorgen Jahnsen, Oslo, Norway
    13:15-13:20 Panel discussion


    Satellite symposium 4a: TiGenix/Takeda
    Plenary Hall, Ground Level, CCIB Barcelona

    TiGenix Logo Updated symposia Takeda

    18:30-19:30 Perianal Crohn's Disease: Exploring a serious burden
    Invitation to Satellite Symposium

    Chair: Michael Kamm, Melbourne, Australia
    18:30-18:40 Crohn's Disease and complex perianal fistula: The scope of the problem and understanding the burden
    Michael Kamm, Melbourne, Australia
    18:40-19:05 Multidisciplinary perspectived on the management of complex perianal fistula: Current challenges
    Michael Kamm, Melbourne, Australia
    Gert Van Assche, Leuven, Belgium
    Andre D'Hoore, Leuven, Belgium
    19:05-19:17 View to the future: Potential new approaches to manage complex perianal fistula
    Alessandro Armuzzi, Rome, Italy
    19:17-19:30 Panel discussion and concluding remarks
    Michael Kamm, Melbourne, Australia

     

    Satellite symposium 4b: Janssen
    Parallel Hall, Room 116+117, Level 1, CCIB Barcelona

    Janssen

    18:30-19:30 Raising the bar: Defining the new era of Crohn's Disease management
    Invitation to Satellite Symposium

    Chair: Subrata Ghosh, Birmingham, United Kingdom
    18:30-18:35 Welcome and overview of learning objectives
    Subrata Ghosh, Birmingham, United Kingdom
    18:35-18:45 Unmet needs: How new ideas will make progress
    Subrata Ghosh, Birmingham, United Kingdom
    18:45-19:00 Long term management: Tailoring treatment to patient profiles and objectives markers
    Iris Dotan, Tel Aviv, Israel
    19:00-19:20 A new era in treatment: IL-12/23 in IBD therapy
    Matthieu Allez, Paris, France
    19:20-19:30 Questions and closing remarks
    Subrata Ghosh, Birmingham, United Kingdom
    Matthieu Allez, Paris, France
  • Satellite symposium 5a: Pfizer
    Plenary Hall, Ground Level, CCIB Barcelona  

    Pfizer 

    07:15-08:15 Evolving Patient and physician expectations in UC Mangement
    Invitation to Satellite Symposium

    Chair: Corey Siegel, New Hampshire, United States
    07:15-07:20 Welcome and Introductions
    Corey Siegel, New Hampshire, United States
    07:20-07:35 Beyond the bowel: Clinical needs of patients with Ulcerative Colitis
    Iris Dotan, Tel Aviv, Israel
    07:35-07:50 Beyond traditional patient engagement: Enhancing communication and shared decision making
    Corey Siegel, New Hampshire, United States
    07:50-08:05 Beyond current therapies and treatment strategies: What can we do to optimize patient outcomes?
    Stefan Schreiber, Kiel Germany
    08:05-08:15 Audience Q&A
     

    Satellite symposium 5b: Boehringer Ingelheim
    Parallel Hall, Room 116+117, Level 1, CCIB Barcelona

    Boehringer Ingelheim

    07:15-08:15 What would the world look like if everybody had Inflammatory Bowel Disease?
    Invitation to Satellite Symposium

    Chair: Walter Reinisch, Vienna, Austria
    07:15-07:25 Opening and introduction
    Walter Reinisch, Vienna, Austria
    07:25-08:10 Interdisciplinary discussion: What would an IBD-focused world look like?
    Discussants:
    Sam Cleasby, Sheffield, United Kingdom
    Niels Vande Casteele, San Diego, United States
    Göran Lindahl, Gothenburg, Sweden
    Sherrilyn Roush, London, United Kingdom
    08:10-08:15 Summary: What can we bring back to our world?
    Walter Reinisch, Vienna, Austria